000 | 01042 a2200289 4500 | ||
---|---|---|---|
005 | 20250515052314.0 | ||
264 | 0 | _c20070104 | |
008 | 200701s 0 0 eng d | ||
022 | _a1538-3598 | ||
024 | 7 |
_a10.1001/jama.296.24.2968 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aColón-Emeric, Cathleen S | |
245 | 0 | 0 |
_aTen vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. _h[electronic resource] |
260 |
_bJAMA _cDec 2006 |
||
300 |
_a2968-9 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlendronate _xtherapeutic use |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFractures, Bone _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdrug therapy |
773 | 0 |
_tJAMA _gvol. 296 _gno. 24 _gp. 2968-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.296.24.2968 _zAvailable from publisher's website |
999 |
_c16758075 _d16758075 |